市場調查報告書

乳腺炎的全球市場:預測

Mastitis Market Research Report Information by Type (Human, Bovine), by Treatment (Antibiotics, Pain Relievers, Surgery, Vaccines, Others), by End-user (Hospitals and Clinics, Veterinary Centers, Others) and Region - Global Forecast till 2023

出版商 Market Research Future 商品編碼 811796
出版日期 內容資訊 英文 142 Pages
訂單完成後即時交付
價格
Back to Top
乳腺炎的全球市場:預測 Mastitis Market Research Report Information by Type (Human, Bovine), by Treatment (Antibiotics, Pain Relievers, Surgery, Vaccines, Others), by End-user (Hospitals and Clinics, Veterinary Centers, Others) and Region - Global Forecast till 2023
出版日期: 2019年02月28日內容資訊: 英文 142 Pages
簡介

本報告提供全球乳腺炎市場相關調查分析,提供市場動態,市場分析,各地區分析,主要企業等相關的系統性資訊。

第1章 序文

第2章 市場簡介

第3章 調查手法

第4章 市場動態

  • 簡介
  • 促進因素
  • 阻礙因素
  • 機會
  • 宏觀經濟

第5章 市場要素分析

  • 波特的五力分析
  • 價值鏈分析
  • 投資機會
  • 價格分析

第6章 全球乳腺炎市場:各類型

  • 簡介

第7章 全球乳腺炎市場:不同治療

  • 簡介

第8章 全球乳腺炎市場:各終端用戶

  • 簡介
  • 獸醫中心
  • 醫院·診所

第9章 全球乳腺炎市場:各地區

  • 簡介
  • 南北美洲
  • 歐洲
  • 亞太地區
  • 中東·非洲

第10章 競爭情形

  • 競爭模式

第11章 企業簡介

  • Bayer AG
  • BioNumerik Pharmaceuticals Inc
  • Oncothyreon Inc
  • Oncogenex
  • Apthera Inc.
  • Zoetis Inc
  • Boehringer Ingelheim GmbH
  • Merck Co. & Inc
  • Astellas Pharma Inc
  • Pfizer Inc.
  • Novartis AG
  • Sanofi S.A.
  • F. Hoffmann-La Roche AG

第12章 附錄

目錄

Market analysis

The mastitis market is mainly growing because of the advancements made in the field of medical sciences. The growing prevalence of this type of contagious diseases amongst human beings, especially women and animals like cow are some of the major factor influencing the global mastitis market positively. Factors driving the market development incorporate the rising instances of breast-related disease and expanding rate of pregnancy. On account of bovines, the unhygienic animal dwelling place conditions are the key driving element behind the market development making the infectious mastitis spread. Besides, the rising awareness about the mastitis conditions, its effective management, and the accessibility of the treatment is broadly encouraging market development. The global mastitis market is growing at a CAGR of 15.07% by targeting the value of USD 7,898.05 million during the forecast period (2017-2023).

Market segmentation

The global mastitis market has been divided on the basis of its treatment, type, end-user, and regional demand. Based on its type, the mastitis market is bifurcated into bovine mastitis and human mastitis. On the basis of its treatment, the mastitis market is classified into pain relievers, antibiotics, vaccines, surgery, and others. Based on its end-user, the mastitis market is segmented into clinics, hospitals, veterinary centers, and others.

Regional analysis

Geographically, the global mastitis market is divided into global regions like Europe, North America, Asia- Pacific, Middle East, LATAM, and Africa.

Major players

Zoetis Inc. (U.S.), Boehringer Ingelheim GmbH (Germany), Merck Co & Inc. (U.S.), Astellas Pharma Inc. (Japan), Pfizer Inc. (U.S.), Novartis AG (Switzerland), BioNumerik Pharmaceuticals Inc. (U.S.), Bayer AG (Germany), Oncothyreon Inc. (U.S.), Oncogenex (U.S.), Apthera Inc. (U.K.), and others are some of the major players in the global mastitis market.

Table of Contents

1 Report Prologue

2 Market Introduction

  • 2.1 Definition
  • 2.2 Scope of the Study
  • 2.3 Research Objective
  • 2.4 Assumptions & Limitations
    • 2.4.1 Assumptions
    • 2.4.2 Limitations
    • 2.4.3 Market Structure

3 Research Methodology

  • 3.1 Primary Research Methodology
  • 3.2 Secondary Research Methodology
  • 3.3 Market Size Estimation
  • 3.4 Forecast Model

4 Market Dynamics

  • 4.1 Introduction
  • 4.2 Drivers
    • 4.2.1 Rising cases of breast cancer
    • 4.2.2 Increasing rate of pregnancy
    • 4.2.3 Unhygienic barn conditions causing contagious mastitis in bovines
  • 4.3 Restraints
    • 4.3.1 Lack of awareness
    • 4.3.2 Complications in diagnosis due to similar symptoms of breast cancer & mastitis
  • 4.4 Opportunity
    • 4.4.1 Entering developing economies
  • 4.5 Macroeconomics
    • 4.5.1 Trends in Mastitis

5 Market Factor Analysis

  • 5.1 Porter's Five Forces Model
    • 5.1.1 Bargaining Power of Suppliers
    • 5.1.2 Bargaining Power of Buyers
    • 5.1.3 Threat of New Entrants
    • 5.1.4 Threat of Substitutes
    • 5.1.5 Intensity of Rivalry
  • 5.2 Value Chain Analysis
    • 5.2.1 R&D & Designing
    • 5.2.2 Manufacturing
    • 5.2.3 Distribution & Sales
    • 5.2.4 Post-Sales Services
  • 5.3 Investment Opportunities
  • 5.4 Price Analysis

6 Global Mastitis Market, By Type

  • 6.1 Introduction
  • 6.2 Bovine
    • 6.2.1 Contagious Mastitis
    • 6.2.2 Environmental Mastitis
    • 6.2.3 Opportunist Mastitis
  • 6.3 Human
    • 6.3.1 Non-Infectious Mastitis
    • 6.3.2 Infectious Mastitis

7 Global Mastitis Market, By Treatment

  • 7.1 Introduction
  • 7.2 Bovine
    • 7.2.1 Antibiotics
    • 7.2.2 Vaccines
  • 7.3 Human
    • 7.3.1 Pain Relievers
    • 7.3.2 Antibiotics

8 Global Mastitis Market, By End User

  • 8.1 Introduction
  • 8.2 Veterinary Centres
  • 8.3 Hospital & Clinics

9 Global Mastitis Market, By Region

  • 9.1 Introduction
  • 9.2 Americas
    • 9.2.1 North America
      • 9.2.1.1 US
      • 9.2.1.2 Canada
    • 9.2.2 South America
  • 9.3 Europe
    • 9.3.1 Western Europe
      • 9.3.1.1 Germany
      • 9.3.1.2 France
      • 9.3.1.3 UK
      • 9.3.1.4 Italy
      • 9.3.1.5 Spain
      • 9.3.1.6 Rest of Western Europe
    • 9.3.2 Eastern Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 Republic of Korea
    • 9.4.6 Rest of Asia Pacific
  • 9.5 Middle East & Africa
    • 9.5.1 Saudi Arabia
    • 9.5.2 United Arab Emirates
    • 9.5.3 Kuwait
    • 9.5.4 Oman
    • 9.5.5 Qatar
    • 9.5.6 Rest of Middle East

10 Competitive Landscape

  • 10.1 Competitive Scenario
    • 10.1.1 Introduction

11 Company Profiles

  • 11.1 Bayer AG
    • 11.1.1 Company Overview
    • 11.1.2 Financial Overview
    • 11.1.3 Products Offering
    • 11.1.4 Key Developments
    • 11.1.5 SWOT Analysis
    • 11.1.6 Key Strategy
  • 11.2 BioNumerik Pharmaceuticals Inc
    • 11.2.1 Company Overview
    • 11.2.2 Financial Overview
    • 11.2.3 Products/Services Offered
    • 11.2.4 Key Developments
    • 11.2.5 SWOT Analysis
    • 11.2.6 Key Strategy
  • 11.3 Oncothyreon Inc
    • 11.3.1 Company Overview
    • 11.3.2 Financial Overview
    • 11.3.3 Products/Services Offered
    • 11.3.4 Key Developments
    • 11.3.5 SWOT Analysis
    • 11.3.6 Key Strategy
  • 11.4 Oncogenex
    • 11.4.1 Company Overview
    • 11.4.2 Financial Overview
    • 11.4.3 Products/Services Offered
    • 11.4.4 Key Developments
    • 11.4.5 SWOT Analysis
    • 11.4.6 Key Strategy
  • 11.5 Apthera Inc.
    • 11.5.1 Company Overview
    • 11.5.2 Financial Overview
    • 11.5.3 Products/Services Offered
    • 11.5.4 Key Developments
    • 11.5.5 SWOT Analysis
    • 11.5.6 Key Strategy
  • 11.6 Zoetis Inc
    • 11.6.1 Company Overview
    • 11.6.2 Financial Overview
    • 11.6.3 Products/Services Offered
    • 11.6.4 Key Developments
    • 11.6.5 SWOT Analysis
    • 11.6.6 Key Strategy
  • 11.7 Boehringer Ingelheim GmbH
    • 11.7.1 Company Overview
    • 11.7.2 Financial Overview
    • 11.7.3 Products/Services Offered
    • 11.7.4 Key Developments
    • 11.7.5 SWOT Analysis
    • 11.7.6 Key Strategy
  • 11.8 Merck Co. & Inc
    • 11.8.1 Company Overview
    • 11.8.2 Financial Overview
    • 11.8.3 Products/Services Offered
    • 11.8.4 Key Developments
    • 11.8.5 SWOT Analysis
    • 11.8.6 Key Strategy
  • 11.9 Astellas Pharma Inc
    • 11.9.1 Company Overview
    • 11.9.2 Financial Overview
    • 11.9.3 Products/Services Offered
    • 11.9.4 Key Developments
    • 11.9.5 SWOT Analysis
    • 11.9.6 Key Strategy
  • 11.1 Pfizer Inc.
    • 11.10.1 Company Overview
    • 11.10.2 Financial Overview
    • 11.10.3 Products/Services Offered
    • 11.10.4 Key Developments
    • 11.10.5 SWOT Analysis
    • 11.10.6 Key Strategy
  • 11.11 Novartis AG
    • 11.11.1 Company Overview
    • 11.11.2 Financial Overview
    • 11.11.3 Products/Services Offered
    • 11.11.4 Key Developments
    • 11.11.5 SWOT Analysis
    • 11.11.6 Key Strategy
  • 11.12 Sanofi S.A.
    • 11.12.1 Company Overview
    • 11.12.2 Financial Overview
    • 11.12.3 Products/Services Offered
    • 11.12.4 Key Developments
    • 11.12.5 SWOT Analysis
    • 11.12.6 Key Strategy
  • 11.13 F. Hoffmann-La Roche AG
    • 11.13.1 Company Overview
    • 11.13.2 Financial Overview
    • 11.13.3 Products/Services Offered
    • 11.13.4 Key Developments
    • 11.13.5 SWOT Analysis
    • 11.13.6 Key Strategy

12 Appendix

  • 12.1 Discussion Blue Print
  • 12.2 References

List of Tables

  • TABLE 1 MARKET SYNOPSIS
  • TABLE 2 PRIMARY INTERVIEWS
  • TABLE 3 GLOBAL MASTITIS MARKET, BY TYPE 2014-2023 (USD MILLION)
  • TABLE 4 GLOBAL MASTITIS MARKET FOR BOVINE, BY TYPE 2014-2023 (USD MILLION)
  • TABLE 5 GLOBAL MASTITIS MARKET FOR BOVINE, BY REGION 2014-2023 (USD MILLION)
  • TABLE 6 GLOBAL MASTITIS MARKET FOR CONTAGIOUS MASTITIS, BY REGION 2014-2023 (USD MILLION)
  • TABLE 7 GLOBAL MASTITIS MARKET FOR ENVIRONMENTAL MASTITIS, BY REGION 2014-2023 (USD MILLION)
  • TABLE 8 GLOBAL MASTITIS MARKET FOR OPPORTUNIST MASTITIS, BY REGION 2014-2023 (USD MILLION)
  • TABLE 9 GLOBAL MASTITIS MARKET FOR HUMAN, BY TYPE 2014-2023 (USD MILLION)
  • TABLE 10 GLOBAL MASTITIS MARKET FOR HUMAN, BY REGION 2014-2023 (USD MILLION)
  • TABLE 11 GLOBAL MASTITIS MARKET FOR NON-INFECTIOUS MASTITIS, BY REGION 2014-2023 (USD MILLION)
  • TABLE 12 GLOBAL MASTITIS MARKET FOR INFECTIOUS MASTITIS, BY REGION 2014-2023 (USD MILLION)
  • TABLE 13 GLOBAL MASTITIS MARKET, BY TREATMENT 2014-2023 (USD MILLION)
  • TABLE 14 GLOBAL MASTITIS MARKET FOR BOVINE, BY TREATMENT TYPE 2014-2023 (USD MILLION)
  • TABLE 15 GLOBAL MASTITIS MARKET FOR ANTIBIOTICS, BY REGION TYPE 2014-2023 (USD MILLION)
  • TABLE 16 GLOBAL MASTITIS MARKET FOR VACCINES, BY REGION 2014-2023 (USD MILLION)
  • TABLE 17 GLOBAL MASTITIS MARKET FOR HUMAN, BY TREATMENT TYPE 2014-2023 (USD MILLION)
  • TABLE 18 GLOBAL MASTITIS MARKET FOR PAIN RELIEVERS, BY REGION TYPE 2014-2023 (USD MILLION)
  • TABLE 19 GLOBAL MASTITIS MARKET FOR ANTIBIOTICS, BY REGION 2014-2023 (USD MILLION)
  • TABLE 20 GLOBAL MASTITIS MARKET, BY END-USER 2014-2023 (USD MILLION)
  • TABLE 21 GLOBAL MASTITIS MARKET FOR VETERINARY CENTRES, BY REGION 2014-2023 (USD MILLION)
  • TABLE 22 GLOBAL MASTITIS MARKET FOR HOSPITAL & CLINICS, BY REGION 2014-2023 (USD MILLION)
  • TABLE 23 GLOBAL MASTITIS MARKET, BY REGION 2014-2023 (USD MILLION)
  • TABLE 24 AMERICAS MASTITIS MARKET, BY REGION 2014-2023 (USD MILLION)
  • TABLE 25 AMERICAS MASTITIS MARKET, BY TYPE 2014-2023 (USD MILLION)
  • TABLE 26 AMERICAS MASTITIS MARKET FOR BOVINE, BY TYPE 2014-2023 (USD MILLION)
  • TABLE 27 AMERICAS MASTITIS MARKET FOR HUMAN, BY TYPE 2014-2023 (USD MILLION)
  • TABLE 28 AMERICAS MASTITIS MARKET, BY TREATMENT 2014-2023 (USD MILLION)
  • TABLE 29 AMERICAS MASTITIS MARKET FOR BOVINE, BY TREATMENT TYPE 2014-2023 (USD MILLION)
  • TABLE 30 AMERICAS MASTITIS MARKET FOR HUMAN, BY TREATMENT TYPE 2014-2023 (USD MILLION)
  • TABLE 31 AMERICAS MASTITIS MARKET, BY END-USER 2014-2023 (USD MILLION)
  • TABLE 32 NORTH AMERICA MASTITIS MARKET, BY COUNTRY 2014-2023 (USD MILLION)
  • TABLE 33 NORTH AMERICA MASTITIS MARKET, BY TYPE 2014-2023 (USD MILLION)
  • TABLE 34 NORTH AMERICA MASTITIS MARKET FOR BOVINE, BY TYPE 2014-2023 (USD MILLION)
  • TABLE 35 NORTH AMERICA MASTITIS MARKET FOR HUMAN, BY TYPE 2014-2023 (USD MILLION)
  • TABLE 36 NORTH AMERICA MASTITIS MARKET, BY TREATMENT 2014-2023 (USD MILLION)
  • TABLE 37 NORTH AMERICA MASTITIS MARKET FOR BOVINE, BY TREATMENT TYPE 2014-2023 (USD MILLION)
  • TABLE 38 NORTH AMERICA MASTITIS MARKET FOR HUMAN, BY TREATMENT TYPE 2014-2023 (USD MILLION)
  • TABLE 39 NORTH AMERICA MASTITIS MARKET, BY END-USER 2014-2023 (USD MILLION)
  • TABLE 40 US MASTITIS MARKET, BY TYPE 2014-2023 (USD MILLION)
  • TABLE 41 US MASTITIS MARKET FOR BOVINE, BY TYPE 2014-2023 (USD MILLION)
  • TABLE 42 US MASTITIS MARKET FOR HUMAN, BY TYPE 2014-2023 (USD MILLION)
  • TABLE 43 US MASTITIS MARKET, BY TREATMENT 2014-2023 (USD MILLION)
  • TABLE 44 US MASTITIS MARKET FOR BOVINE, BY TREATMENT TYPE 2014-2023 (USD MILLION)
  • TABLE 45 US MASTITIS MARKET FOR HUMAN, BY TREATMENT TYPE 2014-2023 (USD MILLION)
  • TABLE 46 US MASTITIS MARKET, BY END-USER 2014-2023 (USD MILLION)
  • TABLE 47 CANADA MASTITIS MARKET, BY TYPE 2014-2023 (USD MILLION)
  • TABLE 48 CANADA MASTITIS MARKET FOR BOVINE, BY TYPE 2014-2023 (USD MILLION)
  • TABLE 49 CANADA MASTITIS MARKET FOR HUMAN, BY TYPE 2014-2023 (USD MILLION)
  • TABLE 50 CANADA MASTITIS MARKET, BY TREATMENT 2014-2023 (USD MILLION)
  • TABLE 51 CANADA MASTITIS MARKET FOR BOVINE, BY TREATMENT TYPE 2014-2023 (USD MILLION)
  • TABLE 52 CANADA MASTITIS MARKET FOR HUMAN, BY TREATMENT TYPE 2014-2023 (USD MILLION)
  • TABLE 53 CANADA MASTITIS MARKET, BY END-USER 2014-2023 (USD MILLION)
  • TABLE 54 SOUTH AMERICA MASTITIS MARKET, BY TYPE 2014-2023 (USD MILLION)
  • TABLE 55 SOUTH AMERICA MASTITIS MARKET FOR BOVINE, BY TYPE 2014-2023 (USD MILLION)
  • TABLE 56 SOUTH AMERICA MASTITIS MARKET FOR HUMAN, BY TYPE 2014-2023 (USD MILLION)
  • TABLE 57 SOUTH AMERICA MASTITIS MARKET, BY TREATMENT 2014-2023 (USD MILLION)
  • TABLE 58 SOUTH AMERICA MASTITIS MARKET FOR BOVINE, BY TREATMENT TYPE 2014-2023 (USD MILLION)
  • TABLE 59 SOUTH AMERICA MASTITIS MARKET FOR HUMAN, BY TREATMENT TYPE 2014-2023 (USD MILLION)
  • TABLE 60 SOUTH AMERICA MASTITIS MARKET, BY END-USER 2014-2023 (USD MILLION)
  • TABLE 61 EUROPE MASTITIS MARKET, BY REGION 2014-2023 (USD MILLION)
  • TABLE 62 EUROPE MASTITIS MARKET, BY TYPE 2014-2023 (USD MILLION)
  • TABLE 63 EUROPE MASTITIS MARKET FOR BOVINE, BY TYPE 2014-2023 (USD MILLION)
  • TABLE 64 EUROPE MASTITIS MARKET FOR HUMAN, BY TYPE 2014-2023 (USD MILLION)
  • TABLE 65 EUROPE MASTITIS MARKET, BY TREATMENT 2014-2023 (USD MILLION)
  • TABLE 66 EUROPE MASTITIS MARKET FOR BOVINE, BY TREATMENT TYPE 2014-2023 (USD MILLION)
  • TABLE 67 EUROPE MASTITIS MARKET FOR HUMAN, BY TREATMENT TYPE 2014-2023 (USD MILLION)
  • TABLE 68 EUROPE MASTITIS MARKET, BY END-USER 2014-2023 (USD MILLION)
  • TABLE 69 WESTERN EUROPE MASTITIS MARKET, BY COUNTRY 2014-2023 (USD MILLION)
  • TABLE 70 WESTERN EUROPE MASTITIS MARKET, BY TYPE 2014-2023 (USD MILLION)
  • TABLE 71 WESTERN EUROPE MASTITIS MARKET FOR BOVINE, BY TYPE 2014-2023 (USD MILLION)
  • TABLE 72 WESTERN EUROPE MASTITIS MARKET FOR HUMAN, BY TYPE 2014-2023 (USD MILLION)
  • TABLE 73 WESTERN EUROPE MASTITIS MARKET, BY TREATMENT 2014-2023 (USD MILLION)
  • TABLE 74 WESTERN EUROPE MASTITIS MARKET FOR BOVINE, BY TREATMENT TYPE 2014-2023 (USD MILLION)
  • TABLE 75 WESTERN EUROPE MASTITIS MARKET FOR HUMAN, BY TREATMENT TYPE 2014-2023 (USD MILLION)
  • TABLE 76 WESTERN EUROPE MASTITIS MARKET, BY END-USER 2014-2023 (USD MILLION)
  • TABLE 77 GERMANY MASTITIS MARKET, BY TYPE 2014-2023 (USD MILLION)
  • TABLE 78 GERMANY MASTITIS MARKET FOR BOVINE, BY TYPE 2014-2023 (USD MILLION)
  • TABLE 79 GERMANY MASTITIS MARKET FOR HUMAN, BY TYPE 2014-2023 (USD MILLION)
  • TABLE 80 GERMANY MASTITIS MARKET, BY TREATMENT 2014-2023 (USD MILLION)
  • TABLE 81 GERMANY MASTITIS MARKET FOR BOVINE, BY TREATMENT TYPE 2014-2023 (USD MILLION)
  • TABLE 82 GERMANY MASTITIS MARKET FOR HUMAN, BY TREATMENT TYPE 2014-2023 (USD MILLION)
  • TABLE 83 GERMANY MASTITIS MARKET, BY END-USER 2014-2023 (USD MILLION)
  • TABLE 84 FRANCE MASTITIS MARKET, BY TYPE 2014-2023 (USD MILLION)
  • TABLE 85 FRANCE MASTITIS MARKET FOR BOVINE, BY TYPE 2014-2023 (USD MILLION)
  • TABLE 86 FRANCE MASTITIS MARKET FOR HUMAN, BY TYPE 2014-2023 (USD MILLION)
  • TABLE 87 FRANCE MASTITIS MARKET, BY TREATMENT 2014-2023 (USD MILLION)
  • TABLE 88 FRANCE MASTITIS MARKET FOR BOVINE, BY TREATMENT TYPE 2014-2023 (USD MILLION)
  • TABLE 89 FRANCE MASTITIS MARKET FOR HUMAN, BY TREATMENT TYPE 2014-2023 (USD MILLION)
  • TABLE 90 FRANCE MASTITIS MARKET, BY END-USER 2014-2023 (USD MILLION)
  • TABLE 91 UK MASTITIS MARKET, BY TYPE 2014-2023 (USD MILLION)
  • TABLE 92 UK MASTITIS MARKET FOR BOVINE, BY TYPE 2014-2023 (USD MILLION)
  • TABLE 93 UK MASTITIS MARKET FOR HUMAN, BY TYPE 2014-2023 (USD MILLION)
  • TABLE 94 UK MASTITIS MARKET, BY TREATMENT 2014-2023 (USD MILLION)
  • TABLE 95 UK MASTITIS MARKET FOR BOVINE, BY TREATMENT TYPE 2014-2023 (USD MILLION)
  • TABLE 96 UK MASTITIS MARKET FOR HUMAN, BY TREATMENT TYPE 2014-2023 (USD MILLION)
  • TABLE 97 UK MASTITIS MARKET, BY END-USER 2014-2023 (USD MILLION)
  • TABLE 98 ITALY MASTITIS MARKET, BY TYPE 2014-2023 (USD MILLION)
  • TABLE 99 ITALY MASTITIS MARKET FOR BOVINE, BY TYPE 2014-2023 (USD MILLION)
  • TABLE 100 ITALY MASTITIS MARKET FOR HUMAN, BY TYPE 2014-2023 (USD MILLION)
  • TABLE 101 ITALY MASTITIS MARKET, BY TREATMENT 2014-2023 (USD MILLION)
  • TABLE 102 ITALY MASTITIS MARKET FOR BOVINE, BY TREATMENT TYPE 2014-2023 (USD MILLION)
  • TABLE 103 ITALY MASTITIS MARKET FOR HUMAN, BY TREATMENT TYPE 2014-2023 (USD MILLION)
  • TABLE 104 ITALY MASTITIS MARKET, BY END-USER 2014-2023 (USD MILLION)
  • TABLE 105 SPAIN MASTITIS MARKET, BY TYPE 2014-2023 (USD MILLION)
  • TABLE 106 SPAIN MASTITIS MARKET FOR BOVINE, BY TYPE 2014-2023 (USD MILLION)
  • TABLE 107 SPAIN MASTITIS MARKET FOR HUMAN, BY TYPE 2014-2023 (USD MILLION)
  • TABLE 108 SPAIN MASTITIS MARKET, BY TREATMENT 2014-2023 (USD MILLION)
  • TABLE 109 SPAIN MASTITIS MARKET FOR BOVINE, BY TREATMENT TYPE 2014-2023 (USD MILLION)
  • TABLE 110 SPAIN MASTITIS MARKET FOR HUMAN, BY TREATMENT TYPE 2014-2023 (USD MILLION)
  • TABLE 111 SPAIN MASTITIS MARKET, BY END-USER 2014-2023 (USD MILLION)
  • TABLE 112 REST OF WESTERN EUROPE MASTITIS MARKET, BY TYPE 2014-2023 (USD MILLION)
  • TABLE 113 REST OF WESTERN EUROPE MASTITIS MARKET FOR BOVINE, BY TYPE 2014-2023 (USD MILLION)
  • TABLE 114 REST OF WESTERN EUROPE MASTITIS MARKET FOR HUMAN, BY TYPE 2014-2023 (USD MILLION)
  • TABLE 115 REST OF WESTERN EUROPE MASTITIS MARKET, BY TREATMENT 2014-2023 (USD MILLION)
  • TABLE 116 REST OF WESTERN EUROPE MASTITIS MARKET FOR BOVINE, BY TREATMENT TYPE 2014-2023 (USD MILLION)
  • TABLE 117 REST OF WESTERN EUROPE MASTITIS MARKET FOR HUMAN, BY TREATMENT TYPE 2014-2023 (USD MILLION)
  • TABLE 118 REST OF WESTERN EUROPE MASTITIS MARKET, BY END-USER 2014-2023 (USD MILLION)
  • TABLE 119 EASTERN EUROPE MASTITIS MARKET, BY TYPE 2014-2023 (USD MILLION)
  • TABLE 120 EASTERN EUROPE MASTITIS MARKET FOR BOVINE, BY TYPE 2014-2023 (USD MILLION)
  • TABLE 121 EASTERN EUROPE MASTITIS MARKET FOR HUMAN, BY TYPE 2014-2023 (USD MILLION)
  • TABLE 122 EASTERN EUROPE MASTITIS MARKET, BY TREATMENT 2014-2023 (USD MILLION)
  • TABLE 123 EASTERN EUROPE MASTITIS MARKET FOR BOVINE, BY TREATMENT TYPE 2014-2023 (USD MILLION)
  • TABLE 124 EASTERN EUROPE MASTITIS MARKET FOR HUMAN, BY TREATMENT TYPE 2014-2023 (USD MILLION)
  • TABLE 125 EASTERN EUROPE MASTITIS MARKET, BY END-USER 2014-2023 (USD MILLION)
  • TABLE 126 ASIA PACIFIC MASTITIS MARKET, BY COUNTRY 2014-2023 (USD MILLION)
  • TABLE 127 ASIA PACIFIC MASTITIS MARKET, BY TYPE 2014-2023 (USD MILLION)
  • TABLE 128 ASIA PACIFIC MASTITIS MARKET FOR BOVINE, BY TYPE 2014-2023 (USD MILLION)
  • TABLE 129 ASIA PACIFIC MASTITIS MARKET FOR HUMAN, BY TYPE 2014-2023 (USD MILLION)
  • TABLE 130 ASIA PACIFIC MASTITIS MARKET, BY TREATMENT 2014-2023 (USD MILLION)
  • TABLE 131 ASIA PACIFIC MASTITIS MARKET FOR BOVINE, BY TREATMENT TYPE 2014-2023 (USD MILLION)
  • TABLE 132 ASIA PACIFIC MASTITIS MARKET FOR HUMAN, BY TREATMENT TYPE 2014-2023 (USD MILLION)
  • TABLE 133 ASIA PACIFIC MASTITIS MARKET, BY END-USER 2014-2023 (USD MILLION)
  • TABLE 134 JAPAN MASTITIS MARKET, BY TYPE 2014-2023 (USD MILLION)
  • TABLE 135 JAPAN MASTITIS MARKET FOR BOVINE, BY TYPE 2014-2023 (USD MILLION)
  • TABLE 136 JAPAN MASTITIS MARKET FOR HUMAN, BY TYPE 2014-2023 (USD MILLION)
  • TABLE 137 JAPAN MASTITIS MARKET, BY TREATMENT 2014-2023 (USD MILLION)
  • TABLE 138 JAPAN MASTITIS MARKET FOR BOVINE, BY TREATMENT TYPE 2014-2023 (USD MILLION)
  • TABLE 139 JAPAN MASTITIS MARKET FOR HUMAN, BY TREATMENT TYPE 2014-2023 (USD MILLION)
  • TABLE 140 JAPAN MASTITIS MARKET, BY END-USER 2014-2023 (USD MILLION)
  • TABLE 141 CHINA MASTITIS MARKET, BY TYPE 2014-2023 (USD MILLION)
  • TABLE 142 CHINA MASTITIS MARKET FOR BOVINE, BY TYPE 2014-2023 (USD MILLION)
  • TABLE 143 CHINA MASTITIS MARKET FOR HUMAN, BY TYPE 2014-2023 (USD MILLION)
  • TABLE 144 CHINA MASTITIS MARKET, BY TREATMENT 2014-2023 (USD MILLION)
  • TABLE 145 CHINA MASTITIS MARKET FOR BOVINE, BY TREATMENT TYPE 2014-2023 (USD MILLION)
  • TABLE 146 CHINA MASTITIS MARKET FOR HUMAN, BY TREATMENT TYPE 2014-2023 (USD MILLION)
  • TABLE 147 CHINA MASTITIS MARKET, BY END-USER 2014-2023 (USD MILLION)
  • TABLE 148 INDIA MASTITIS MARKET, BY TYPE 2014-2023 (USD MILLION)
  • TABLE 149 INDIA MASTITIS MARKET FOR BOVINE, BY TYPE 2014-2023 (USD MILLION)
  • TABLE 150 INDIA MASTITIS MARKET FOR HUMAN, BY TYPE 2014-2023 (USD MILLION)
  • TABLE 151 INDIA MASTITIS MARKET, BY TREATMENT 2014-2023 (USD MILLION)
  • TABLE 152 INDIA MASTITIS MARKET FOR BOVINE, BY TREATMENT TYPE 2014-2023 (USD MILLION)
  • TABLE 153 INDIA MASTITIS MARKET FOR HUMAN, BY TREATMENT TYPE 2014-2023 (USD MILLION)
  • TABLE 154 INDIA MASTITIS MARKET, BY END-USER 2014-2023 (USD MILLION)
  • TABLE 155 AUSTRALIA MASTITIS MARKET, BY TYPE 2014-2023 (USD MILLION)
  • TABLE 156 AUSTRALIA MASTITIS MARKET FOR BOVINE, BY TYPE 2014-2023 (USD MILLION)
  • TABLE 157 AUSTRALIA MASTITIS MARKET FOR HUMAN, BY TYPE 2014-2023 (USD MILLION)
  • TABLE 158 AUSTRALIA MASTITIS MARKET, BY TREATMENT 2014-2023 (USD MILLION)
  • TABLE 159 AUSTRALIA MASTITIS MARKET FOR BOVINE, BY TREATMENT TYPE 2014-2023 (USD MILLION)
  • TABLE 160 AUSTRALIA MASTITIS MARKET FOR HUMAN, BY TREATMENT TYPE 2014-2023 (USD MILLION)
  • TABLE 161 AUSTRALIA MASTITIS MARKET, BY END-USER 2014-2023 (USD MILLION)
  • TABLE 162 REPUBLIC OF KOREA MASTITIS MARKET, BY TYPE 2014-2023 (USD MILLION)
  • TABLE 163 REPUBLIC OF KOREA MASTITIS MARKET FOR BOVINE, BY TYPE 2014-2023 (USD MILLION)
  • TABLE 164 REPUBLIC OF KOREA MASTITIS MARKET FOR HUMAN, BY TYPE 2014-2023 (USD MILLION)
  • TABLE 165 REPUBLIC OF KOREA MASTITIS MARKET, BY TREATMENT 2014-2023 (USD MILLION)
  • TABLE 166 REPUBLIC OF KOREA MASTITIS MARKET FOR BOVINE, BY TREATMENT TYPE 2014-2023 (USD MILLION)
  • TABLE 167 REPUBLIC OF KOREA MASTITIS MARKET FOR HUMAN, BY TREATMENT TYPE 2014-2023 (USD MILLION)
  • TABLE 168 REPUBLIC OF KOREA MASTITIS MARKET, BY END-USER 2014-2023 (USD MILLION)
  • TABLE 169 REST OF ASIA PACIFIC MASTITIS MARKET, BY TYPE 2014-2023 (USD MILLION)
  • TABLE 170 REST OF ASIA PACIFIC MASTITIS MARKET FOR BOVINE, BY TYPE 2014-2023 (USD MILLION)
  • TABLE 171 REST OF ASIA PACIFIC MASTITIS MARKET FOR HUMAN, BY TYPE 2014-2023 (USD MILLION)
  • TABLE 172 REST OF ASIA PACIFIC MASTITIS MARKET, BY TREATMENT 2014-2023 (USD MILLION)
  • TABLE 173 REST OF ASIA PACIFIC MASTITIS MARKET FOR BOVINE, BY TREATMENT TYPE 2014-2023 (USD MILLION)
  • TABLE 174 REST OF ASIA PACIFIC MASTITIS MARKET FOR HUMAN, BY TREATMENT TYPE 2014-2023 (USD MILLION)
  • TABLE 175 REST OF ASIA PACIFIC MASTITIS MARKET, BY END-USER 2014-2023 (USD MILLION)
  • TABLE 176 MIDDLE EAST & AFRICA MASTITIS MARKET, BY REGION 2014-2023 (USD MILLION)
  • TABLE 177 MIDDLE EAST & AFRICA MASTITIS MARKET, BY TYPE 2014-2023 (USD MILLION)
  • TABLE 178 MIDDLE EAST & AFRICA MASTITIS MARKET FOR BOVINE, BY TYPE 2014-2023 (USD MILLION)
  • TABLE 179 MIDDLE EAST & AFRICA MASTITIS MARKET FOR HUMAN, BY TYPE 2014-2023 (USD MILLION)
  • TABLE 180 MIDDLE EAST & AFRICA MASTITIS MARKET, BY TREATMENT 2014-2023 (USD MILLION)
  • TABLE 181 MIDDLE EAST & AFRICA MASTITIS MARKET FOR BOVINE, BY TREATMENT TYPE 2014-2023 (USD MILLION)
  • TABLE 182 MIDDLE EAST & AFRICA MASTITIS MARKET FOR HUMAN, BY TREATMENT TYPE 2014-2023 (USD MILLION)
  • TABLE 183 MIDDLE EAST & AFRICA MASTITIS MARKET, BY END-USER 2014-2023 (USD MILLION)
  • TABLE 184 SAUDI ARABIA MASTITIS MARKET, BY TYPE 2014-2023 (USD MILLION)
  • TABLE 185 SAUDI ARABIA MASTITIS MARKET FOR BOVINE, BY TYPE 2014-2023 (USD MILLION)
  • TABLE 186 SAUDI ARABIA MASTITIS MARKET FOR HUMAN, BY TYPE 2014-2023 (USD MILLION)
  • TABLE 187 SAUDI ARABIA MASTITIS MARKET, BY TREATMENT 2014-2023 (USD MILLION)
  • TABLE 188 SAUDI ARABIA MASTITIS MARKET FOR BOVINE, BY TREATMENT TYPE 2014-2023 (USD MILLION)
  • TABLE 189 SAUDI ARABIA MASTITIS MARKET FOR HUMAN, BY TREATMENT TYPE 2014-2023 (USD MILLION)
  • TABLE 190 SAUDI ARABIA MASTITIS MARKET, BY END-USER 2014-2023 (USD MILLION)
  • TABLE 191 UNITED ARAB EMIRATES MASTITIS MARKET, BY TYPE 2014-2023 (USD MILLION)
  • TABLE 192 UNITED ARAB EMIRATES MASTITIS MARKET FOR BOVINE, BY TYPE 2014-2023 (USD MILLION)
  • TABLE 193 UNITED ARAB EMIRATES MASTITIS MARKET FOR HUMAN, BY TYPE 2014-2023 (USD MILLION)
  • TABLE 194 UNITED ARAB EMIRATES MASTITIS MARKET, BY TREATMENT 2014-2023 (USD MILLION)
  • TABLE 195 UNITED ARAB EMIRATES MASTITIS MARKET FOR BOVINE, BY TREATMENT TYPE 2014-2023 (USD MILLION)
  • TABLE 196 UNITED ARAB EMIRATES MASTITIS MARKET FOR HUMAN, BY TREATMENT TYPE 2014-2023 (USD MILLION)
  • TABLE 197 UNITED ARAB EMIRATES MASTITIS MARKET, BY END-USER 2014-2023 (USD MILLION)
  • TABLE 198 KUWAIT MASTITIS MARKET, BY TYPE 2014-2023 (USD MILLION)
  • TABLE 199 KUWAIT MASTITIS MARKET FOR BOVINE, BY TYPE 2014-2023 (USD MILLION)
  • TABLE 200 KUWAIT MASTITIS MARKET FOR HUMAN, BY TYPE 2014-2023 (USD MILLION)
  • TABLE 201 KUWAIT MASTITIS MARKET, BY TREATMENT 2014-2023 (USD MILLION)
  • TABLE 202 KUWAIT MASTITIS MARKET FOR BOVINE, BY TREATMENT TYPE 2014-2023 (USD MILLION)
  • TABLE 203 KUWAIT MASTITIS MARKET FOR HUMAN, BY TREATMENT TYPE 2014-2023 (USD MILLION)
  • TABLE 204 KUWAIT MASTITIS MARKET, BY END-USER 2014-2023 (USD MILLION)
  • TABLE 205 OMAN MASTITIS MARKET, BY TYPE 2014-2023 (USD MILLION)
  • TABLE 206 OMAN MASTITIS MARKET FOR BOVINE, BY TYPE 2014-2023 (USD MILLION)
  • TABLE 207 OMAN MASTITIS MARKET FOR HUMAN, BY TYPE 2014-2023 (USD MILLION)
  • TABLE 208 OMAN MASTITIS MARKET, BY TREATMENT 2014-2023 (USD MILLION)
  • TABLE 209 OMAN MASTITIS MARKET FOR BOVINE, BY TREATMENT TYPE 2014-2023 (USD MILLION)
  • TABLE 210 OMAN MASTITIS MARKET FOR HUMAN, BY TREATMENT TYPE 2014-2023 (USD MILLION)
  • TABLE 211 OMAN MASTITIS MARKET, BY END-USER 2014-2023 (USD MILLION)
  • TABLE 212 QATAR MASTITIS MARKET, BY TYPE 2014-2023 (USD MILLION)
  • TABLE 213 QATAR MASTITIS MARKET FOR BOVINE, BY TYPE 2014-2023 (USD MILLION)
  • TABLE 214 QATAR MASTITIS MARKET FOR HUMAN, BY TYPE 2014-2023 (USD MILLION)
  • TABLE 215 QATAR MASTITIS MARKET, BY TREATMENT 2014-2023 (USD MILLION)
  • TABLE 216 QATAR MASTITIS MARKET FOR BOVINE, BY TREATMENT TYPE 2014-2023 (USD MILLION)
  • TABLE 217 QATAR MASTITIS MARKET FOR HUMAN, BY TREATMENT TYPE 2014-2023 (USD MILLION)
  • TABLE 218 QATAR MASTITIS MARKET, BY END-USER 2014-2023 (USD MILLION)
  • TABLE 219 REST OF MIDDLE EAST & AFRICA MASTITIS MARKET, BY TYPE 2014-2023 (USD MILLION)
  • TABLE 220 REST OF MIDDLE EAST & AFRICA MASTITIS MARKET FOR BOVINE, BY TYPE 2014-2023 (USD MILLION)
  • TABLE 221 REST OF MIDDLE EAST & AFRICA MASTITIS MARKET FOR HUMAN, BY TYPE 2014-2023 (USD MILLION)
  • TABLE 222 REST OF MIDDLE EAST & AFRICA MASTITIS MARKET, BY TREATMENT 2014-2023 (USD MILLION)
  • TABLE 223 REST OF MIDDLE EAST & AFRICA MASTITIS MARKET FOR BOVINE, BY TREATMENT TYPE 2014-2023 (USD MILLION)
  • TABLE 224 REST OF MIDDLE EAST & AFRICA MASTITIS MARKET FOR HUMAN, BY TREATMENT TYPE 2014-2023 (USD MILLION)
  • TABLE 225 REST OF MIDDLE EAST & AFRICA MASTITIS MARKET, BY END-USER 2014-2023 (USD MILLION)

List of Figures

  • FIGURE 1 TOP-DOWN & BOTTOM-UP APPROACHES
  • FIGURE 2 MARKET DYNAMICS: ANALYSIS OF THE GLOBAL MASTITIS MARKET
  • FIGURE 3 PORTER'S FIVE FORCES ANALYSIS: GLOBAL MASTITIS MARKET
  • FIGURE 4 VALUE CHAIN: GLOBAL MASTITIS MARKET
  • FIGURE 5 GLOBAL MASTITIS MARKET, BY TYPE 2017 & 2023
  • FIGURE 6 GLOBAL MASTITIS MARKET, BY TREATMENT 2017 & 2023
  • FIGURE 7 GLOBAL MASTITIS MARKET, BY END-USER 2017 & 2023
  • FIGURE 8 GLOBAL MASTITIS MARKET, BY REGION 2017 & 2023
  • FIGURE 9 AMERICAS MASTITIS MARKET SHARE, BY REGION 2017
  • FIGURE 10 NORTH AMERICA MASTITIS MARKET SHARE, BY COUNTRY 2017
  • FIGURE 11 EUROPE MASTITIS MARKET SHARE, BY REGION 2017
  • FIGURE 12 WESTERN EUROPE MASTITIS MARKET SHARE, BY COUNTRY 2017
  • FIGURE 13 ASIA PACIFIC MASTITIS MARKET SHARE, BY COUNTRY 2017
  • FIGURE 14 MIDDLE EAST & AFRICA MASTITIS MARKET SHARE, BY REGION 2017
  • FIGURE 15 GLOBAL MASTITIS MARKET, MARKET SHARE ANALYSIS 2017 (%)
Back to Top